Synthon Hispania, S.L. (manufacturing, primary and secondary packaging, quality control, batch release)

The drug is used in combination with prednisone or prednisolone for the treatment of adult men with metastatic prostate cancer: newly diagnosed high-risk hormone-sensitive, as well as castration-resistant (mild course after androgen blockade or progressing after docetaxel chemotherapy).

Dosage form: tablets

ATC: L02BX03

The drug is prescribed for adult men for the treatment of metastatic prostate cancer (both hormone-sensitive high-risk and castration-resistant).

Dosage form: tablets, film-coated

ATC: L02BX03

The drug is prescribed for adults to lower cholesterol levels (specifically LDL cholesterol) in hypercholesterolemia or mixed dyslipidemia. It is used as an adjunct to diet, particularly in combination with statins (if they do not provide the desired effect) or for patients who do not tolerate statins.

Dosage form: tablets, film-coated

ATC: C10AX15

The drug is indicated for adults with elevated cholesterol levels (hypercholesterolemia) or mixed dyslipidemia. It is used as adjunctive therapy to lower LDL cholesterol levels, particularly in patients who cannot achieve target levels with statins or who have an intolerance to them.

Dosage form: tablets, film-coated

ATC: C10BA10